Lung cancer treatment research enters a new era

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-10-19 03:30 GMT | Update On 2023-10-19 10:17 GMT

Advances in lung cancer treatment highlight importance of tumour testing at diagnosis

Research presented at the ESMO Congress 2023 sets potential major changes in first-line treatment for patients with NSCLC with targetable tumour cell mutations

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023.

Better outcomes were achieved with combinations of experimental new drugs targeting common and rare tumour mutations than with standard treatments, with improvements seen in both early and late-stage NSCLC – the type of lung cancer responsible for approximately eight out of 10 cases of the disease.

Results of NSCLC studies presented at the ESMO Congress 2023 also suggest that using mutation-targeted treatment can reduce the need for chemotherapy in some patients, including those with some rarer tumour alterations for which targeted treatment options have previously been limited.

In addition, study data reinforce the value of adding immunotherapy to chemotherapy in some types of NSCLC, including the use of this treatment before surgery for patients with operable cancers to shrink tumours and indicate likely response to further treatment after surgery (so called, neoadjuvant treatment).

Reference: Lung cancer treatment research enters a new era; EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Lung cancer treatment research enters a new era

Similar News

New Liquid Biopsy May Detect HPV-Related Cancers 10 Years Before Symptoms: Study Finds

How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out

New Urine Test May Detect Prostate Cancer with 91 Percent Accuracy: Study

India Sees Higher Cancer Incidence in Women but Greater Mortality in Men: ICMR Study

This Diet May Cut Risk of Cancer and Heart Disease Multimorbidity: Study Suggests

Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor

One Workout May Trigger Tumor-Suppressing Proteins in Cancer Survivors: Study Shows

New Web-Based Tool Aims to Cut Lung Cancer Deaths with Tailored Strategies, Reveals Research